Screener
Monte Rosa Therapeutics, Inc. GLUE Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
| (in thousands, except share and per share amounts) | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Unrealized loss on available-for-sale securities | (473) | (97) | (1,447) | (118) |
| Comprehensive (loss) income | $(43,816) | $(12,339) | $(89,238) | $34,573 |
| (Loss) earnings per share: | ||||
| Basic | $(0.43) | $(0.15) | $(0.87) | $0.42 |
| Diluted | $(0.43) | $(0.15) | $(0.87) | $0.42 |
| Weighted average number of shares outstanding: | ||||
| Basic | 101,478,945 | 82,186,768 | 100,685,824 | 82,167,849 |
| Diluted | 101,478,945 | 82,186,768 | 100,685,824 | 82,890,063 |
Item 1. Financial Statements
FAQ
- What is Monte Rosa Therapeutics, Inc.'s shares (diluted)?
- Monte Rosa Therapeutics, Inc. (GLUE) reported shares (diluted) of 101.5M in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s shares (diluted) increased by 23.5% year-over-year, from 82.2M to 101.5M.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Monte Rosa Therapeutics, Inc.'s shares (diluted) has grown at a 43.6% compound annual growth rate (CAGR), from 77.8M to 330.6M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Monte Rosa Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude